Withholding Proton Pump Inhibitors to Prevent Recurrent C difficile

Clostridium difficile causes almost half a million infections annually among hospitalized and community-dwelling patients in the United States, and approximately 1 in 5 patients will develop a recurrent C difficile infection.1 Therefore, identification of modifiable risk factors for incident and…

Read the full article here

Related Articles